申请人:Yanagimachi Mamoru
公开号:US20130095068A1
公开(公告)日:2013-04-18
Provided is an imidazolylbenzene compound or salt thereof that controls HCV replication and in addition is particularly capable of strongly controlling HCV replication, and is very effective in the prevention and treatment of HCV infection when used in combination with another agent for treating HCV infection such as Interferon.